Secondary Logo

Journal Logo

Articles by Federico Pulido

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

Macías, Juan; González, Juan; Tural, Cristina; More

AIDS. 28(9):1279-1287, June 1st, 2014.

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

Arribas, Jose R; Horban, Andrzej; Gerstoft, Jan; More

AIDS. 24(2):223-230, January 2010.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

Pulido, Federico; Arribas, José R; Delgado, Rafael; More

AIDS. 22(2):F1-F9, January 11th, 2008.

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/μl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients)

Arribas, Jose R.; Pulido, Federico; Miró, Jose M.; More

AIDS. 16(11):1554-1556, July 26th, 2002.

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

Laguna, Fernando; López-Vélez, Rogelio; Pulido, Federico; More

AIDS. 13(9):1063-1069, June 18th, 1999.